- Round ID
- FR-00215
- Stage
- Series B
- Round name
- Series B (plus a separate ~€40M growth round in Aug 2023 co-led by World Fund/CPT Capital)
- Amount
- €42M (~$51M)
Dated funding evidence
Enough (formerly 3F Bio)
Series B · €42M (~$51M) · 2021-06-01
Reported round€42M (~$51M)Series B
- Disclosure date
- 2021-06-01
- Reported currency
- EUR
- Companies House
- SC496410
- Evidence sources
- 3
2021-06-01Series B€42M (~$51M)
Resolved investor records
1 additional source-listed name is retained in the record fields below but not linked without an exact canonical match.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Nutreco, Olympic Investments (Onassis Foundation)
- Other investors
- AXA IM Alts, HAL Investments, Tailored Solutions
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.